PETS

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 4

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F3 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $5.3998 to $5.4300. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 8

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Leslie C.G. Campbell 2020 Irrevocable Trust

Disclosed balance after: 15,000

F6 · ownership.nature: These shares are held in a trust for the benefit of the family members of the reporting person. The spouse of the reporting person is trustee of the trust, but the reporting person is not a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 7

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Leslie C.G. Campbell 2020 Irrevocable Trust

Disclosed balance after: 10,000

F6 · ownership.nature: These shares are held in a trust for the benefit of the family members of the reporting person. The spouse of the reporting person is trustee of the trust, but the reporting person is not a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 3

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 2

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

F2 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $5.3550 to $5.3600. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 1

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $5.3899 to $5.3900. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001040130-24-000111 · wk-form4_1727467903.xml · nonDerivative · entry 1

D'Elia Robyn M. · CIK 0001743283 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Inducement Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of September 27, 2024, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0002035815-25-000007 · wk-form4_1757622642.xml · nonDerivative · entry 1

KRULIK DOUGLAS · CIK 0002035815 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Inducement Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of September 27, 2024, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001213900-24-089056 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,078,000

F1 · balance_after: Includes (i) 1,550,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

SEC source: 0001040130-24-000093 · wk-form4_1724101539.xml · nonDerivative · entry 1

Smith Jacqueline Paula · CIK 0001906429 · Vice President of People

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,099

SEC source: 0001040130-24-000091 · wk-form4_1723251765.xml · nonDerivative · entry 1

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,510

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan, which vest on August 8, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000089 · wk-form4_1723235303.xml · nonDerivative · entry 1

Solivan Leah · CIK 0002028705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,443

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan, which vest on August 8, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000087 · wk-form4_1723235177.xml · nonDerivative · entry 1

Mennen Justin L. · CIK 0001789515 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,873

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan, which vest on August 8, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000085 · wk-form4_1723235073.xml · nonDerivative · entry 1

PURCEL DIANA G · CIK 0001270545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,375

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan, which vest on August 8, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000083 · wk-form4_1723234903.xml · nonDerivative · entry 1

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan, which vest on August 8, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000056 · wk-form4_1719949219.xml · nonDerivative · entry 1

Solivan Leah · CIK 0002028705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 943

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan, which vest on June 24, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000039 · wk-form4_1717619467.xml · nonDerivative · entry 1

Mennen Justin L. · CIK 0001789515 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,373

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan, which vest on June 3, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000036 · wk-form4_1717524006.xml · derivative · entry 2

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2026-06-15

F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.

F3 · shares: Represents the forfeiture as a result of the Agreement of 8,000 performance stock units granted pursuant to the 2022 Plan on June 15, 2023.

F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.

SEC source: 0001040130-24-000036 · wk-form4_1717524006.xml · nonDerivative · entry 1

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,146

F1 · shares: Represents the forfeiture as a result of the Transition and Separation Agreement dated May 31, 2024 between the Company and the reporting person ("Agreement") of (i) 3,917 restricted stock units granted pursuant to the PetMed Express, Inc.'s 2022 Employee Equity Compensation Plan ("2022 Plan") on June 15, 2023, and (ii) 37,425 restricted stock units granted pursuant to the 2022 Plan on May 16, 2024.

SEC source: 0001040130-24-000030 · wk-form4_1716241598.xml · nonDerivative · entry 1

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,488

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2022 Employee Equity Compensation Plan. Twenty percent of the RSUs vest on June 30, 2024, thirty percent vest on August 31, 2024, and fifty percent vest on August 31, 2025, all subject to continued employment with the Company through the applicable vesting date (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-24-000026 · wk-form4_1714588006.xml · nonDerivative · entry 1

Hulett Mathew N · CIK 0001713988 · Former Officer and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,850

F1 · shares: Represents forfeiture of restricted performance stock granted pursuant to the PetMed Express, Inc.'s 2016 Employee Equity Compensation Restricted Stock Plan on August 30, 2021, as a result of cessation of employment.

SEC source: 0001040130-24-000024 · wk-form4_1714587714.xml · nonDerivative · entry 2

Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 490,592

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2022 Employee Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of April 29, 2024, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000089 · wk-form4_1702418103.xml · nonDerivative · entry 1

Moseley Mark Bradley JR · CIK 0001908085 · Chief Technology Info Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

F1 · shares: Includes 14,000 shares of restricted stock under the Company's 2022 Employee Equity Compensation Plan, which stock restrictions will lapse pro rata in one-third increments on each of December 1, 2024, December 1, 2025, and December 1, 2026, subject to forfeiture in the event of termination of employment. Mr. Moseley retains voting rights over all the shares subject to forfeiture while in escrow.

SEC source: 0001040130-23-000086 · wk-form4_1699894353.xml · nonDerivative · entry 2

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,510

F1 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $7.20 to $7.44. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001040130-23-000084 · wk-form4_1699384614.xml · nonDerivative · entry 1

Hulett Mathew N · CIK 0001713988 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 613,850

F1 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $7.225 to $7.27. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001040130-23-000082 · wk-form4_1699384206.xml · nonDerivative · entry 1

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,888

F1 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $7.255 to $7.27. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001040130-23-000066 · wk-form4_1692205409.xml · nonDerivative · entry 2

Smith Jacqueline Paula · CIK 0001906429 · Vice President of People

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2022 Employee Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of August 14, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000060 · wk-form4_1691172264.xml · nonDerivative · entry 2

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of August 3, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000058 · wk-form4_1691172018.xml · nonDerivative · entry 2

Campos Sandra Yvette · CIK 0001865087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of August 3, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000056 · wk-form4_1691171856.xml · nonDerivative · entry 2

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of August 3, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000054 · wk-form4_1691171663.xml · nonDerivative · entry 2

PURCEL DIANA G · CIK 0001270545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of August 3, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000042 · wk-form4_1687284018.xml · derivative · entry 3

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2026-06-15

F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.

F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.

SEC source: 0001040130-23-000042 · wk-form4_1687284018.xml · nonDerivative · entry 2

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

F1 · kind: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc.'s (the "Company") 2022 Employee Equity Compensation Restricted Stock Plan, as amended and restated (the "Plan"). One-third of the RSUs vest on each of the first, second and third anniversaries of June 15, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

SEC source: 0001040130-23-000038 · wk-form4_1686605316.xml · nonDerivative · entry 1

Chambers Christine · CIK 0001848090 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

F1 · shares: Represents the forfeiture of performance-based restricted performance stock granted to the reporting person on August 3, 2022, the restrictions for which shares were eligible to lapse based on the attainment of certain financial performance objectives. Upon grant, the target amount of shares was reported in Table I of the reporting person's Form 3. On June 8, 2023, the Company determined that, based on the Company's performance over the applicable performance period, the 3,000 restricted performance shares would be forfeited.

SEC source: 0001040130-23-000030 · wf-form4_168484484485961.xml · nonDerivative · entry 1

Moseley Mark Bradley JR · CIK 0001908085 · Chief Technology Info Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

SEC source: 0001040130-23-000034 · wf-form4_168497571717608.xml · nonDerivative · entry 1

Pingree Daniel Job · CIK 0001906511 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

SEC source: 0001437749-22-018244 · rdgdoc.xml · nonDerivative · entry 1

Cobb Peter · CIK 0001713337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Cobb retains voting rights over all the shares while in escrow.

SEC source: 0001437749-22-018243 · rdgdoc.xml · nonDerivative · entry 1

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Campbell retains voting rights over all the shares while in escrow.

SEC source: 0001437749-22-018242 · rdgdoc.xml · nonDerivative · entry 1

Watson Jodi · CIK 0001866128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,880

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow.

SEC source: 0001437749-22-018240 · rdgdoc.xml · nonDerivative · entry 1

PURCEL DIANA G · CIK 0001270545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,375

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Purcel retains voting rights over all the shares while in escrow.

SEC source: 0001437749-22-018241 · rdgdoc.xml · nonDerivative · entry 1

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,510

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow.

SEC source: 0001040130-23-000064 · wk-form4_1692205243.xml · nonDerivative · entry 1

Smith Jacqueline Paula · CIK 0001906429 · Vice President of People

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,700

F1 · date: The late filing was due to administrative oversight by the Company that was not the fault of the reporting person.

F2 · shares: Includes 7,350 shares of restricted stock ("RSA") under the Company's 2022 Employee Equity Compensation Restricted Stock Plan, which stock restrictions will lapse pro rata in one-third increments on each of the first, second and third anniversaries of July 28, 2022, subject to forfeiture in the event of termination of employment (except as provided in the RSA agreement). Ms. Smith retains voting rights over all the shares subject to forfeiture while in escrow.

SEC source: 0001437749-22-000765 · rdgdoc.xml · nonDerivative · entry 1

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Campbell retains voting rights over all the shares while in escrow.

SEC source: 0001437749-22-000764 · rdgdoc.xml · nonDerivative · entry 1

Watson Jodi · CIK 0001866128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,380

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow.

SEC source: 0001437749-21-018461 · rdgdoc.xml · nonDerivative · entry 1

KORN RONALD J · CIK 0001249320 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,833

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Korn retains voting rights over all the shares while in escrow.

SEC source: 0001437749-21-018460 · rdgdoc.xml · nonDerivative · entry 1

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Campbell retains voting rights over all the shares while in escrow.

SEC source: 0001437749-21-018459 · rdgdoc.xml · nonDerivative · entry 1

Watson Jodi · CIK 0001866128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,880

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Ms. Watson retains voting rights over all the shares while in escrow.

SEC source: 0001437749-21-018457 · rdgdoc.xml · nonDerivative · entry 1

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,010

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow.

SEC source: 0001437749-21-018456 · rdgdoc.xml · nonDerivative · entry 1

ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,450

F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow.

SEC source: 0001437749-21-014149 · rdgdoc.xml · nonDerivative · entry 1

ROSENBLOOM BRUCE S · CIK 0001251340 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,525

F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan, which was executed on February 18, 2021, that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy.